Literature DB >> 31497450

A Pedunculated Skin Lesion in a Case of Clear Cell Renal Carcinoma.

Meghana Kesireddy1, Amit Correa2, Raoul Correa3, Rohit Venkatesan2.   

Abstract

Clear cell type renal carcinoma accounts for about 80% of all renal cell carcinomas. We present a 39-year-old male with clear cell renal carcinoma of the right kidney, stage I: T1 b (5 cm) N0 M0, who developed cutaneous metastases in the right submandibular region 28 months after nephrectomy. Our case is unique as i) the patient with stage I cancer (at the time of nephrectomy) presented with an isolated cutaneous nodule in a location distant from the primary site; ii) cutaneous nodule developed while being treated with pazopanib for metastatic lesions in the lung and adrenal; and iii) nivolumab and ipilimumab combination therapy decreased the vascularity of the nodule though it did not halt the nodule growth. Physicians should be knowledgeable about this rare clinical entity and its varied presentation. Further studies are necessary to determine optimal treatment, as the current therapeutic agents for metastatic renal carcinoma might not be adequate for cutaneous metastasis.

Entities:  

Keywords:  cutaneous; metastasis; renal carcinoma; treatment

Year:  2019        PMID: 31497450      PMCID: PMC6716742          DOI: 10.7759/cureus.5021

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  9 in total

1.  Cutaneous metastases in renal cell carcinoma: a systematic review and a case report.

Authors:  Rikard Ohlsson; Louise Geertsen; Stine Berge Stuveseth; Lars Lund
Journal:  Scand J Urol       Date:  2019-04-02       Impact factor: 1.612

2.  Cutaneous metastases in renal cell carcinoma.

Authors:  L N Dorairajan; A K Hemal; M Aron; T P Rajeev; M Nair; A Seth; P N Dogra; N P Gupta
Journal:  Urol Int       Date:  1999       Impact factor: 2.089

3.  Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience.

Authors:  Jean-Jacques Patard; Emmanuelle Leray; Nathalie Rioux-Leclercq; Luca Cindolo; Vincenzo Ficarra; Amnon Zisman; Alexandre De La Taille; Jacques Tostain; Walter Artibani; Claude C Abbou; Bernard Lobel; François Guillé; Dominique K Chopin; Peter F A Mulders; Christopher G Wood; David A Swanson; Robert A Figlin; Arie S Belldegrun; Allan J Pantuck
Journal:  J Clin Oncol       Date:  2005-04-20       Impact factor: 44.544

4.  Updated European Association of Urology Guidelines: Recommendations for the Treatment of First-line Metastatic Clear Cell Renal Cancer.

Authors:  Thomas Powles; Laurence Albiges; Michael Staehler; Karim Bensalah; Saeed Dabestani; Rachel H Giles; Fabian Hofmann; Milan Hora; Markus A Kuczyk; Thomas B Lam; Lorenzo Marconi; Axel S Merseburger; Sergio Fernández-Pello; Rana Tahbaz; Alessandro Volpe; Börje Ljungberg; Axel Bex
Journal:  Eur Urol       Date:  2017-12-07       Impact factor: 20.096

5.  Renal cell carcinoma with solitary toe metastasis.

Authors:  Sisto Perdonà; Riccardo Autorino; Luigi Gallo; Marco DE Sio; Luigi Marra; Luigi Claudio; Corrado Caracò; Renato Franco; Flavio Fazzioli; Antonio Gallo
Journal:  Int J Urol       Date:  2005-04       Impact factor: 3.369

6.  Distribution of metastatic sites in renal cell carcinoma: a population-based analysis.

Authors:  M Bianchi; M Sun; C Jeldres; S F Shariat; Q-D Trinh; A Briganti; Z Tian; J Schmitges; M Graefen; P Perrotte; M Menon; F Montorsi; P I Karakiewicz
Journal:  Ann Oncol       Date:  2011-09-02       Impact factor: 32.976

7.  Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients.

Authors:  D P Lookingbill; N Spangler; K F Helm
Journal:  J Am Acad Dermatol       Date:  1993-08       Impact factor: 11.527

8.  Metastatic renal cell carcinoma to the head and neck: summary of 21 cases.

Authors:  Gavin Langille; S Mark Taylor; Martin J Bullock
Journal:  J Otolaryngol Head Neck Surg       Date:  2008-08

9.  Metastatic patterns of renal carcinoma: an analysis of 687 necropsies.

Authors:  L Weiss; J P Harlos; J Torhorst; B Gunthard; F Hartveit; E Svendsen; W L Huang; E Grundmann; M Eder; M Zwicknagl
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.